Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

67.71 -0.02 (-0.03%)
Delayed Quote Updated: 11:08 AM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
Analyst Expectations For GeneDx Holdings's Future ↗
 
Via Benzinga
News headline image
This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday ↗
 
Via Benzinga
News headline image
GeneDx Announces Completion of Fabric Genomics Acquisition
From GeneDx
Via Business Wire
News headline image
Why Investors Were Avoiding GeneDx Holdings Stock This Week ↗
Via The Motley Fool
News headline image
Earnings Scheduled For April 30, 2025 ↗
 
Via Benzinga
News headline image
Retail Buzz Swirls Around GeneDx As Shares Sink 43% Despite Earnings Beat ↗
GeneDx shares plunged 43% despite strong Q1 results and raised guidance, drawing a surge in retail investor interest. The drop followed the company's first sequential test volume decline, which it... 
Via Stocktwits
News headline image
Wednesday's session: top gainers and losers ↗
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
News headline image
Top stock movements in today's session. ↗
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Wednesday's session: gap up and gap down stocks ↗
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Why GeneDx Holdings Stock Is Plunging Today ↗
Via The Motley Fool
News headline image
Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher ↗
 
Via Benzinga
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
S&P 500 Falls 2%; Caterpillar Reports Downbeat Q1 Results ↗
 
Via Benzinga
Topics Stocks
News headline image
IBD 50 Stock GeneDx Hammered Despite Earnings Beat-And-Raise ↗
The company is an expert in using whole genome and exome sequencing to screen for genetic diseases. 
Via Investor's Business Daily
Topics Government
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
GeneDx Reports First Quarter 2025 Financial Results and Business Highlights
From GeneDx
Via Business Wire
News headline image
Exploring high growth characteristics of GENEDX HOLDINGS CORP (NASDAQ:WGS). ↗
UA fundamental and technical analysis of (NASDAQ:WGS): nlocking the high Growth Potential of GENEDX HOLDINGS CORP (NASDAQ:WGS). 
Via Chartmill
News headline image
GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million ↗
GeneDx (NASDAQ: WSG) to acquire Fabric Genomics, pioneer in AI-powered genomic interpretation, for up to $51 million. Expanding global reach and improving precision diagnostics. 
Via Benzinga
News headline image
IBD 50's GeneDx Inks $84 Million AI-Tied Takeover Deal ↗
GeneDx will pay up to $84 million to acquire Fabric Genomics for its AI-powered genomics interpretation platform. 
Via Investor's Business Daily
Topics Artificial Intelligence
News headline image
GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale
From GeneDx
Via Business Wire
News headline image
Why GENEDX HOLDINGS CORP (NASDAQ:WGS) could fit Mark Minervini’s high-growth criteria ↗
A fundamental and technical analysis of (NASDAQ:WGS): Should you consider GENEDX HOLDINGS CORP (NASDAQ:WGS) for high growth investing? 
Via Chartmill
News headline image
GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025
From GeneDx
Via Business Wire
News headline image
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication
From GeneDx
Via Business Wire
News headline image
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GeneDx
Via Business Wire
News headline image
Unlocking the high Growth Potential of GENEDX HOLDINGS CORP (NASDAQ:WGS). ↗
Exploring high growth characteristics of GENEDX HOLDINGS CORP (NASDAQ:WGS). A fundamental and technical analysis of (NASDAQ:WGS). 
Via Chartmill
News headline image
Does GENEDX HOLDINGS CORP (NASDAQ:WGS) align with Mark Minervini’s trading strategy? ↗
A fundamental and technical analysis of (NASDAQ:WGS): Why the high growth investor may take a look at GENEDX HOLDINGS CORP (NASDAQ:WGS). 
Via Chartmill
News headline image
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies
From GeneDx
Via Business Wire
News headline image
GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting
From GeneDx
Via Business Wire
News headline image
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis
From GeneDx
Via Business Wire
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.